CORONAVIRUS/Adimmune gets green light to start human trials of COVID-19 vaccine
08/20/2020 05:49 PM
Taipei, Aug. 20 (CNA) An experimental COVID-19 vaccine developed by Taiwanese maker Adimmune Corp. has been given the green light to start human trials, making it the first in the country to receive approval, Taiwan's Food and Drug Administration (FDA) said Thursday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
More in CORONAVIRUS
![4 schools in Taipei's Wanhua to close amid rising local COVID-19 cases]()
4 schools in Taipei's Wanhua to close amid rising local COVID-19 casesAmid a rise in locally transmitted COVID-19 cases, the Taipei City government on Sunday announced that four elementary schools in the city's Wanhua District will close for one ...05/16/2021 08:48 PM![CECC urges awareness of COVID-19 contact tracing scam]()
CECC urges awareness of COVID-19 contact tracing scamThe Central Epidemic Command Center (CECC) has received reports of scammers pretending to be from local health authorities in order to obtain people's personal information, ...05/16/2021 07:13 PM![Taiwan introduces control measures amid spike in local COVID-19 cases]()
Taiwan introduces control measures amid spike in local COVID-19 casesTaiwan on Sunday rolled out a slew of COVID-19 control measures for medical institutions amid the country's surging domestic infections of the virus, including lowering hospital ...05/16/2021 06:43 PM
Latest
- Society
Taiwan headline news
05/17/2021 10:30 AM - Business
Taiwan shares open lower
05/17/2021 09:23 AM - Culture
4 schools in Taipei's Wanhua to close amid rising local COVID-19 cases
05/16/2021 08:48 PM - Society
67-year-old Taiwanese man attacked in L.A. in suspected hate crime
05/16/2021 07:51 PM - Society
Electronic card users urged to register information online
05/16/2021 07:34 PM
